Gilead Sciences price

$169.18$0.00 (--)
Last updated on Nov 21, 2026, 08:29:39.
Market cap
$209.76B
Circulating supply
--
All-time high
$170.87
24h volume
$3.5

About Gilead Sciences

Gilead Sciences, Inc. is a global biopharmaceutical enterprise, with operations spanning the United States, Europe, and numerous international markets. Its core mission involves discovering, developing, and commercializing innovative medications to address critical health needs. The company's extensive product portfolio encompasses treatments for a variety of severe conditions. For HIV/AIDS, it supplies key therapies such as Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/Eviplera, Stribild, and Atripla. In response to the 2019 coronavirus pandemic, Gilead provides Veklury, an injectable drug for intravenous administration. Its offerings for liver diseases include Epclusa, Harvoni, Vosevi, Vemlidy, and Viread. Furthermore, Gilead assists patients battling hematological disorders, various cancers, and those undergoing cell therapy, through products like Yescarta, Tecartus, Trodelvy, and Zydelig. Other specialized medicines include Letairis, an oral drug for pulmonary arterial hypertension; Ranexa, also an oral medication, for chronic angina; and AmBisome, a liposomal formulation designed to combat serious invasive fungal infections. Gilead Sciences, Inc. actively engages in collaboration agreements with a diverse range of partners to advance its therapeutic pipeline. These include Arcus Biosciences, Inc., Pionyr Immunotherapeutics Inc., Tizona Therapeutics, Inc., Tango Therapeutics, Inc., Jounce Therapeutics, Inc., Galapagos NV, Janssen Sciences Ireland Unlimited Company, Japan Tobacco, Inc., Gadeta B.V., Bristol-Myers Squibb Company, Dragonfly Therapeutics, Inc., and Merck & Co, Inc. The company was founded in 1987 and its corporate headquarters are situated in Foster City, California.

Stock ticker
GILD
Company
Gilead Sciences, Inc.
Industry
Healthcare
Category
US
Stock split / reverse split
12
Launch date
Jan 22, 1992
Listed exchange
NASDAQ

Financials

Q3 FY2026 Earnings
Report period: Jul 1, 2026 – Sep 30, 2026

Summary: GILD reported Revenue of 8.30B (+6.83%), beating expectations; EPS of 2.55 (+3.24%), beating expectations.

Revenue (USD)Beat8.30B+6.83%7.81B+4.83%494.51M+6.33%
EPS (USD)Beat2.55+3.23%2.19+2.81%0.36+16.43%
Financial estimates
● Actual● Estimate
Q3 2025Q4 2025Q1 2026Q2 2026Q3 2026
2.431.741.61-8.451.94
+143.00%+22.53%+54.80%-641.67%-20.17%
● EPS● YoY
Q3 2025Q4 2025Q1 2026Q2 2026Q3 2026
58.53B59.02B56.28B49.36B51.41B
37.08B36.41B32.85B37.62B38.45B
63.34%61.67%58.36%76.20%74.79%
● Assets● Liabilities● Ratio
Q3 2025Q4 2025Q1 2026Q2 2026Q3 2026
4.11B3.33B2.54B3.57B5.04B
-4.67%+11.83%+44.79%+332.04%+22.59%
● CFO● YoY

Shareholders

Shareholders
BLACKROCK, INC.9.80%
VANGUARD CAPITAL MANAGEMENT LLC6.52%
FMR LLC5.37%
STATE STREET CORP4.92%
CAPITAL WORLD INVESTORS3.29%
Others70.06%
Institutions
% Owned90.18%+3.71%
Shares held1.12B+46.17M
Institutions2,373-34
% OwnedPrice
Name% OwnedChange
BLACKROCK, INC.9.80%+2.83M
VANGUARD CAPITAL MANAGEMENT LLC6.52%+436.96K
FMR LLC5.37%-5.04M
STATE STREET CORP4.92%+1.36M
CAPITAL WORLD INVESTORS3.29%-294.96K

Dividends

Dividends
Last ex-dividend: Dec 15, 2026 Cash dividend: 0.82 USD per share
Dividend yield TTM
2.40%
Payout ratio LFY
46.60%
Frequency
Quarterly
20222023202420252026
2.923.003.083.163.28
+3.30%+3.66%+3.35%+2.63%+1.96%
Dividend amount (USD)Dividend yield
Stock splits
Launch date: Jan 22, 1992
DateRatio
Jan 28, 20131 → 2
Jun 25, 20071 → 2
Sep 7, 20041 → 2
Mar 8, 20021 → 2
Feb 22, 20011 → 2
Trade on the go with the OKX app

Gilead Sciences’s recent prices

Past year----
3 months----
30 days----
7 days+0.58%$168.2

Gilead Sciences performance

$169.18
Gilead Sciences price today

Gilead Sciences price today is $169.18, marking a -- over the past 24 hours. On OKX, today’s Gilead Sciences trading volume reached 0.00, worth over $3.50.

$170.87
Gilead Sciences all-time high

Gilead Sciences achieved its all-time high price of $170.87 on Nov 16, 2026. At today’s price of $169.18, Gilead Sciences price is now -0.99% lower than its historic high.

$169.18
Gilead Sciences in USD

The current Gilead Sciences to USD conversion rate is $169.18 per Gilead Sciences.

Guides

Find out how to buy Gilead Sciences

Getting started with crypto can feel overwhelming, but learning where and how to buy crypto is simpler than you might think. Kickstart your journey on the OKX mobile app, or right here on the web.

Dive in

Predict Gilead Sciences’s prices

How much will Gilead Sciences be worth over the next few years? Check out the community’s thoughts and make your predictions.

Forecast

View Gilead Sciences’s price history

Track your Gilead Sciences’s price history to monitor your holdings’ performance over time. You can easily view the open and close values, highs, lows, and trading volume using the table below.

Check it out

More to explore

Gilead Sciences FAQ

Gilead Sciences can offer strong returns, but is also subject to market volatility. Whether it’s a good investment depends on your risk tolerance, goals, and market conditions. Gilead Sciences’s price can be influenced by various factors such as adoption, regulation, technological advancement, and overall market sentiment. Always do your own research before buying Gilead Sciences and never buy more than you can afford to lose. This content is for informational purposes only and isn’t financial advice.

To buy Gilead Sciences at a low price, monitor the market closely and use tools like price alerts and technical indicators to keep you updated on price trends. Always do your own research and use secure platforms. This content is for informational purposes only and isn’t financial advice.

Depending on where you’re located, you can use bank transfer, credit/debit card, or Peer-to-Peer. Read our guide on how to use these different payment methods to buy Gilead Sciences xGILD safely on a trusted exchange like OKX.

Currently, one Gilead Sciences is worth 169.18. For answers and insight into Gilead Sciences’s price action, you’re in the right place. Explore the latest Gilead Sciences charts and trade responsibly with OKX.

To read this Gilead Sciences price chart, hover over or click on the time period you want to view. Hover over the chart to view the corresponding price, displayed in your local currency.

Yes, Gilead Sciences’s price is updated in real-time on our Gilead Sciences price page. You can view the current price and historical price data here at all times.

Countries and regions differ on how digital assets transactions and holdings are taxed and how they view digital assets in general (money, property, commodity). In general, it is expected that you will pay capital gains tax when selling or swapping Gilead Sciences xGILD. Refer here for a more detailed guide.

Staking and earning rewards with Gilead Sciences are subject to local restrictions. Log in or sign up to view products available in your country, region, or state of residence.

Disclaimer

The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.

OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.